DD-723 Phase III Clinical Trial (Breast)
Phase 3
- Conditions
- Subjects with breast tumor
- Registration Number
- JPRN-jRCT2080221250
- Lead Sponsor
- DAIICHISANKYO Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Subjects with focal breast tumors
- Subjects scheduled to undergo pathological examination
- Subjects aged >=20 years old at the time of informed consent
Exclusion Criteria
- Items listed on the package insert (including absolute contraindications, careful administration, and precautions) to ensure safety
- Items related to safety and ethics
- Items related to surgery, procedures, and treatment influencing efficacy and safety assessment for DD-723
- Subjects who are pregnant, possibly pregnant, or lactating
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method